EPTQ S300 Regulatory Status: Key Considerations for Professional Sourcing

EPTQ S300 is a hyaluronic acid (HA) dermal filler manufactured by Jetema, a South Korean pharmaceutical company. The product is designed for aesthetic indications and is part of a broader range of HA fillers produced by Jetema. Professionals sourcing HA fillers from reputable manufacturers like Jetema often prioritize products with established origins due to the implied quality control and adherence to manufacturing standards.

Like other hyaluronic acid dermal fillers in its category, such as D.Fill Medium, EPTQ S300 is developed under controlled conditions. Its South Korean origin indicates a primary compliance with the country's stringent medical device regulations, which form the basis for international market access efforts.

As a product manufactured in South Korea, EPTQ S300 is subject to the regulatory oversight of the Korean Ministry of Food and Drug Safety (KFDA). KFDA approval is a prerequisite for domestic market distribution and signals adherence to national safety and quality standards for medical devices and aesthetic products. Manufacturers like Jetema also typically comply with Good Manufacturing Practices (GMP).

GMP certification ensures that products are consistently produced and controlled according to quality standards. This covers all aspects of production, from raw materials to manufacturing processes and final product release. Clinics should consider these foundational certifications when evaluating the quality framework of sourced products.

For distribution within the European Union and certain other markets that recognize the CE Mark, products like EPTQ S300 require specific certification. The CE Mark indicates that a product complies with EU health, safety, and environmental protection standards. This allows for free movement of the product within the European Economic Area.

Clinics operating in the EU or UK must ensure that any HA filler they procure possesses valid CE marking, or equivalent local authorization. [VERIFY: specific CE Mark certification for EPTQ S300 and its Notified Body] is crucial for verifying legal importation and distribution within these regions.

Beyond Korea and the EU, regulatory approval varies significantly. For the United States market, FDA approval is required. [VERIFY: specific FDA approval status for EPTQ S300]. This is a distinct and often lengthy process that most international products may or may not pursue.

In the Gulf Cooperation Council (GCC) countries and Latin America (LATAM), individual national health authorities (e.g., SFDA in Saudi Arabia, ANVISA in Brazil) maintain their own medical device registration processes. These often involve recognizing existing international certifications like the CE Mark or KFDA approval as part of their assessment. Professionals should consult local regulations for specific import and distribution requirements for [EPTQ S300 regulatory status].

The global market for aesthetic injectables includes parallel imports, where products are legitimately manufactured but imported through channels other than the manufacturer's authorized distributor in a specific region. While often legal, parallel imports can complicate traceability and warranty claims. Professionals must exercise diligence when sourcing, especially when reviewing pricing options such as those detailed in the D.Fill Hard Wholesale Price Guide.

To mitigate risks, clinics should partner with suppliers who provide clear documentation of product origin and supply chain. This practice safeguards against counterfeit products and ensures access to authentic stock with verifiable batch numbers.

When sourcing EPTQ S300 or any other aesthetic injectable, clinic owners and practitioners must demand comprehensive documentation from their suppliers. This includes certificates of authenticity, batch numbers, and proof of proper cold chain management where applicable. These documents are vital for verifying product legitimacy and adherence to regulatory standards.

Responsible sourcing involves more than just price comparison; it requires verifying that the supplier can provide verifiable regulatory compliance for the specific markets. This practice helps clinics maintain high standards of patient safety and operational integrity. For a broader selection of certified products, explore our Hyaluronic acid dermal filler catalog.